The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 3-O-((5-carboxy)1H-benzo[d]imidazole-2-ylmethyl)-methoxy)-beta-D-galactopyranoside ID: ALA4876385
PubChem CID: 164625971
Max Phase: Preclinical
Molecular Formula: C16H20N2O8
Molecular Weight: 368.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OCc2nc3ccc(C(=O)O)cc3[nH]2)[C@H]1O
Standard InChI: InChI=1S/C16H20N2O8/c1-24-16-13(21)14(12(20)10(5-19)26-16)25-6-11-17-8-3-2-7(15(22)23)4-9(8)18-11/h2-4,10,12-14,16,19-21H,5-6H2,1H3,(H,17,18)(H,22,23)/t10-,12+,13-,14+,16-/m1/s1
Standard InChI Key: HTARSASDRNDJSE-QPVMMRRFSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
41.8583 -4.3171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8583 -5.1422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5704 -5.5506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2825 -5.1422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2825 -4.3171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5704 -3.9004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.5704 -6.3757 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.1444 -5.5557 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.9983 -3.9067 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.1426 -3.9067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1402 -3.0816 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.9965 -5.5557 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.7116 -4.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8559 -6.7882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8559 -7.6132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1927 -8.1008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.5276 -8.1008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.2728 -8.8855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4507 -8.8853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0413 -9.5960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4527 -10.3073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2779 -10.3035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6836 -9.5923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6940 -11.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2849 -11.7326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.5190 -11.0120 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
3 7 1 1
2 8 1 1
5 9 1 1
1 10 1 1
10 11 1 0
4 12 1 6
9 13 1 0
7 14 1 0
14 15 1 0
15 16 2 0
16 19 1 0
18 17 1 0
17 15 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
22 24 1 0
24 25 2 0
24 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.34Molecular Weight (Monoisotopic): 368.1220AlogP: -0.77#Rotatable Bonds: 6Polar Surface Area: 154.36Molecular Species: ACIDHBA: 8HBD: 5#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.96CX Basic pKa: 4.94CX LogP: -2.14CX LogD: -4.18Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.44Np Likeness Score: 0.68
References 1. Hassan M, van Klaveren S, Håkansson M, Diehl C, Kovačič R, Baussière F, Sundin AP, Dernovšek J, Walse B, Zetterberg F, Leffler H, Anderluh M, Tomašič T, Jakopin Ž, Nilsson UJ.. (2021) Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation., 223 [PMID:34225180 ] [10.1016/j.ejmech.2021.113664 ]